Pediatric hypertension: managing the transition to adulthood

  • Gidding SS & al.
  • Hypertension
  • 1 Apr 2019

  • International Clinical Digest
Access to the full content of this site is available only to registered healthcare professionals. Access to the full content of this site is available only to registered healthcare professionals.


  • For hypertension, in the transition from childhood to adulthood, a patient will have the same treatment target and hypertension stage and similar medication choices.
  • Long-term risk stratification to age 40 years for pediatric patients remains a gap.

Why this matters

  • These authors say that the guidelines should remain separate for the populations while emphasizing awareness of the transition stage.

Key results

  • The guidelines are similar in the kind of information they provide, including BP measurement technique and health disparities.
  • In both cases, multiple measurements are recommended, emphasizing ambulatory or home monitoring.
  • Both guidelines emphasize lifestyle management for stage I hypertension. 
  • They differ in special populations they emphasize because of intrinsic differences for some conditions by age.
  • Recommendations for diagnostic evaluation are similar, with lipid profile, blood chemistry, urinalysis, and evaluating for secondary hypertension.
  • Specific to pediatric is renal ultrasound in young patients, HbA1c and liver function evaluation, and suspicion for secondary causes in children without overweight/obesity.
  • Specific to adult guidelines are complete blood count, thyroid evaluation, and ECG.
  • After age 13 years, categories of diagnosis are the same.
  • Pediatric-adult care transition remains unsatisfactory for treatment adherence.
  • Trials in children and young adults ages 20-40 years are lacking, leaving gaps.

Please confirm your acceptance

To gain full access to GPnotebook please confirm:

By submitting here you confirm that you have accepted Terms of Use and Privacy Policy of GPnotebook.